Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibody-drug conjugate
antibody-drug conjugate
Merck's ADC hunt continues with second deal for China biotech Kelun
Endpoints
Tue, 07/26/22 - 05:24 pm
Merck
antibody-drug conjugate
solid tumors
China
Kelun Biotech
Astellas pumps $90m into Sutro immuno-oncology alliance
Pharmaforum
Tue, 06/28/22 - 10:35 am
Astellas
Sutro BioPharma
antibody-drug conjugate
cancer
immuno-oncology
US: Merck doubles production capacity of ADC components
Biopharma Reporter
Thu, 06/23/22 - 07:54 pm
Merck
antibody-drug conjugate
drug manufacturing
ADC Space Continues to Thrive with Four More Companies Linking Up
BioSpace
Thu, 06/16/22 - 10:30 am
antibody-drug conjugate
Exelixis
Bioinvent
Oxford BioTherapeutics
Immunogen
EHA: ADC preps filings for Hodgkin lymphoma drug after ph2 readout
Pharmaforum
Mon, 06/13/22 - 10:46 am
ADC Therapeutics
antibody-drug conjugate
camidanlumab tesirine
EMA
relapsed or refractory Hodgkins lymphoma
ASCO22: New data backs BMS’ investment in Eisai’s first cancer ADC
Pharmaforum
Mon, 06/6/22 - 11:52 pm
ASCO 2022
Eisai
antibody-drug conjugate
Bristol Myers Squibb
MORAb-202
At ESMO, three studies show promise of antibody-drug conjugates in breast cancer
Pharmaforum
Mon, 05/30/22 - 10:23 am
ESMO
breast cancer
antibody-drug conjugate
AstraZeneca
Amid Waves of Biotech Layoffs, ADC Developers like ImmunoGen are Thriving
BioSpace
Mon, 05/9/22 - 09:58 am
layoffs
antibody-drug conjugate
Seagen
Immunogen
BrickBio Debuts Powerful Advantage of Novel ADCs, Protein Origami, and Synthetic Virology at 2022 AACR
BioSpace
Mon, 04/11/22 - 10:56 am
BrickBio
antibody-drug conjugate
protein origami
AACR
Immunogen's phase 3 ADC survival data spook investors, sending stock down ahead of FDA filing
Fierce Biotech
Mon, 03/21/22 - 10:17 am
Immunogen
mirvetuximab soravtansine
ovarian cancer
clinical trials
antibody-drug conjugate
Sanofi steps off the sidelines to ink 3 ADC deal with Seagen, reigniting long-held interest in the modality
Fierce Biotech
Wed, 03/16/22 - 10:38 am
Sanofi
Seagen
antibody-drug conjugate
cancer
oncology
Lilly reunites with ImmunoGen to expand into ADCs, paying $13M upfront and $1.7B on the back end
Fierce Biotech
Tue, 02/15/22 - 10:35 am
Eli Lilly
Immunogen
antibody-drug conjugate
ADCs in the pipeline: FDA spells out clinical pharmacology musts for sponsors
Endpoints
Mon, 02/7/22 - 11:21 pm
FDA
regulatory
antibody-drug conjugate
Clinical Pharmacology
J&J's Janssen inks $1B biobucks pact for Mersana's ADC tech in 3 targets
Fierce Biotech
Thu, 02/3/22 - 11:18 am
JNJ
Janssen
Mersana
antibody-drug conjugate
biobucks
With $415M on the line, Genmab taps Synaffix for antibody-drug conjugate technologies
Fierce Biotech
Tue, 01/4/22 - 10:41 am
Genmab
Synaffix
antibody-drug conjugate
FDA gives Daiichi Sankyo’s HER3 drug a breakthrough tag
Pharmaforum
Thu, 12/23/21 - 11:53 am
Daiichi Sankyo
FDA
antibody-drug conjugate
lung cancer
HER3
patritumab deruxtecan
Startup Mythic Therapeutics emerges with $103M to control fate of ADC cancer drugs
MedCity News
Thu, 12/16/21 - 12:02 pm
Mythic Therapeutics
antibody-drug conjugate
startups
cancer
lung cancer
oncology
ASH: Roche's antibody-drug conjugate Polivy added to chemo-antibody combo boosts survival in early-stage lymphoma
Endpoints
Tue, 12/14/21 - 11:12 am
ASH2021
Roche
antibody-drug conjugate
Polivy
Genentech
blood cancers
ImmunoGen lines up FDA filing as antibody-drug conjugate shrinks tumors in pivotal trial
Fierce Biotech
Tue, 11/30/21 - 10:29 am
Immunogen
mirvetuximab soravtansine
ovarian cancer
FDA
antibody-drug conjugate
Daiichi jettisons ADC after flunking early solid tumor test
Fierce Biotech
Fri, 10/29/21 - 10:34 am
Daiichi Sankyo
antibody-drug conjugate
GIST
DS-6157
solid tumors
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »